Revision history
MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes — 1 version recorded. Nothing here has been overwritten.
-
MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes